期刊文献+

盐酸氨溴索不同给药途径治疗肺炎患者的临床效果评价

ambroxol hydrochloride in the treatment of pneumonia patients with different ways of administration
暂未订购
导出
摘要 目的研究以不同给药途径使用盐酸氨溴索治疗肺炎的临床效果。方法选取2014年5月~2015年3月在河南省平顶山市第四人民医院接受治疗的123例肺炎患者,随机分为A、B、C三个小组,每组各41例,A组采取雾化吸入盐酸氨溴索的给药方式,B组采取静脉滴注盐酸氨溴索的给药方式,C组采取口服盐酸氨溴索的给药方式。对比三组患者的临床治疗效果。结果经治疗,A组的临床治疗总有效率、住院时间、炎症因子水平明显优于B、C两组,其差异具有统计学意义(P<0.05)。结论对于肺炎患者来说,使用盐酸氨溴索进行治疗时,采取雾化吸入盐酸氨溴索的给药方式治疗效果最佳,可有效的提升临床治疗率,缩短住院时间,改善炎症因子水平,值得在肺炎的临床治疗中推广。 Objective To evaluate the clinical effect of ambroxol hydrochloride in the treatment of pneumonia patients with different routes of administration. Methods 123 cases of pneumonia treated in our hospital from May 2014 to March 2015 were selected and randomly divided into three groups(A, B, and C)with 41 cases in each group. The patients in group A received nebulized inhalation of ambroxol hydrochloride, and the patients in group B received intravenous drip of ambroxol hydrochloride, while the patients in group C received oral administration of ambroxol hydrochloride. The clinical effect of three groups of patients was compared. Results After treatment, the total effective rate, length of stay and inflammatory factors in group A were significantly better than those in group B and C(P 0.05). The differences among them were statistically significant(P 0.05). Conclusion The use of ambroxol hydrochloride for treatment of patients with pneumonia through inhalation of ambroxol administration had the best curative effect, effectively improve the clinical cure rate, shorten the hospitalization time, improve the level of inflammatory factors, which was worthy of promotion in clinical treatment of pneumonia.
作者 郭艳涛 GUO Yan-tao(Internal Medicine Department,the Fourth People’s Hospital of Pingdingshan,Pingdingshan,Henan,467000,China)
出处 《临床研究》 2018年第7期35-36,共2页 Clinical Research
关键词 盐酸氨溴索 不同给药途径 肺炎患者 临床效果 ambroxol hydrochloride different ways of administration patients with pneumonia clinical effect
  • 相关文献

参考文献7

二级参考文献64

  • 1Beasley MB, Franks TJ, Galvin JR, et al. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage[J]. Arch Pathol Lab Med, 2002, 126(9): 1064-1070.
  • 2Damas C, Morais A, Moura CS, et al. Acute fibrinous and organizing pneumonia[J]. Rev Port Pneumol, 2006, 12(5): 615- 620.
  • 3Lee SM, parkJJ, Sung SH, et al. Acute fibrinous and organizing pneumonia following hematopoietic stem cell transplantation [J]. KoreanJ Intern Med, 2009, 24(2): 156-159.
  • 4Cincotta DR, Sebire NJ, Lim E, et al. Fatal acute fibrinous and organizing pneumonia in an infant: The histopathologic variability of acute respiratory distress syndrome [J]. Pediatr Crit Care Med, 2007, 8(4): 378-382.
  • 5Bhatti S, Hakeem A, Torrealba J, et al. Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: successful treatment with mycophenolate mofetil and corticosteroids [J]. Respir Med, 2009, 103 (11): 1764-1767.
  • 6Hariri LP, Unizony S, Stone J, et al. Acute fibrinous and organizing pneumonia in systemic lupus erythematosus: a case report and review of the literature[J]. Pathol Int, 2010, 60(11): 755-759.
  • 7Heo JY, Song JY Noh JY, et al. Acute fibrinous and organizing pneumonia in a patient with HIV infection and Pneumocystis jiroveci pneumonia [ J]. Respirology, 2010, 15 (8): 1259-1261.
  • 8Mittal V, Kulshrestha R, Arya A, et al. Acute fibrinous and organising pneumonia presenting as complete lung consolidation[J]. Singapore MedJ, 2011, 52(5): e88-e90.
  • 9Valim V, Rocha RH, Couto RB, et al. Acute fibrinous and organizing pneumonia and undifferentiated connective tissue disease: a case report[J]. Case Rep Rheumatol, 2012, 2012: 549298.
  • 10Rapaka V, Hussain MA Niazi M, et al. Severe acute fibrinous and organizing pneumonia causing acute respiratory distress syndrome and shock[J]. J Bronchology Interv Pulmonol, 2011, 18(3): 26%273.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部